Liver News and Research

RSS

A blood test for pre-eclampsia could be in the pipeline

A condition in pregnancy which costs the lives of thousands of babies each year may soon be identified by a simple blood test long before symptoms develop.

28 Oct 2008

Chance of dying from cancer before the age of 84 is falling

The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.

19 Oct 2008

Historical accounts of lovesickness

Modern lovers could learn a thing or two from their Elizabethan counterparts about the pains and pleasures of frustrated passion, according to a new book by Dr Lesel Dawson, Senior Lecturer in English at the University of Bristol.

19 Oct 2008

Resveratrol shows promise for treating human alcoholic fatty liver disease

The accumulation of fat in the liver as a result of chronic alcohol consumption could be prevented by consuming resveratrol, according to a new study with mice. The research found that resveratrol reduced the amount of fat produced in the liver of mice fed alcohol and, at the same time, increased the rate at which fat within the liver is broken down.

14 Oct 2008

Link found between bisphenol A and heart disease

British scientists have revealed a possible link between the chemical bisphenol A (BPA) and disease in adults.

13 Oct 2008

Bisphenol A linked to diabetes and heart disease in adults

A research team from the Peninsula Medical School, the University of Exeter, the University of Plymouth and the University of Iowa, have found evidence linking Bisphenol A (BPA) to diabetes and heart disease in adults.

12 Oct 2008

FDA continues review of Takeda's NDA for Alogliptin

Takeda Pharmaceutical Company Limited has announced that Takeda Global Research and Development Center, Inc., a wholly owned United States (U.S.) subsidiary, received notification that the U.S. Food and Drug Administration (FDA) will not be able to complete its review of the alogliptin New Drug Application (NDA) by the Prescription Drug User Fee Act (PDUFA) date of October 27, 2008.

12 Oct 2008

FDA approves Rapaflo for treatment of symptoms due to benign prostatic hyperplasia

The U.S. Food and Drug Administration today approved Rapaflo (silodosin) capsules for the treatment of symptoms due to benign prostatic hyperplasia (BPH), a condition also known as an enlarged prostate.

12 Oct 2008

Painkillers found to reduce breast cancer risk

According to an international study the regular use of popular painkillers such as aspirin and ibuprofen reduces the risk of breast cancer.

12 Oct 2008

Lilly to acquire ImClone Systems for $6.5 billion

Eli Lilly and Company and ImClone Systems Inc. today announced that the boards of directors of both companies have approved a definitive merger agreement under which Lilly will acquire ImClone through an all cash tender offer of $70.00 per share, or approximately $6.5 billion.

6 Oct 2008

Studies examine ability of antiretroviral Maraviroc to control HIV viral loads

According to two studies sponsored by drugmaker Pfizer and published in the New England Journal of Medicine on Wednesday, the antiretroviral drug maraviroc, which is sold as Selzentry by Pfizer, might help control viral loads among HIV-positive people who have shown resistance to other treatments, Reuters reports.

5 Oct 2008

Exelixis files investigational new drug application for anticancer compound

Exelixis, Inc. announced today that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for XL888, a novel anticancer compound. XL888 is an orally available small molecule inhibitor of HSP90, which is a chaperone protein that promotes the activity and stability of a range of key regulatory proteins, including kinases.

2 Oct 2008

Cholesterol research, begun in the 'Little Skate,' Garners Award

New research on the way the body processes cholesterol has earned a scientist at the University of Rochester Medical Center one of the highest honors in the field.

2 Oct 2008

Nanoparticles, so small, seep right through the skin

Scientists are warning that tiny particles - nanoparticles - are so small that they can be absorbed through the skin.

1 Oct 2008

Surgical treatment provides new option for some colorectal cancer patients

Research out of Wake Forest University School of Medicine suggests that a surgical technique not traditionally used in advanced abdominal cancer may be a viable treatment option for some patients previously thought to be untreatable, offering the real possibility of extending survival for those patients.

30 Sep 2008

When particles are so small that they seep right through skin

Scientists are finding that particles that are barely there - tiny objects known as nanoparticles that have found a home in electronics, food containers, sunscreens, and a variety of applications - can breech our most personal protective barrier: The skin.

30 Sep 2008

Concert Pharmaceuticals initiates CTP-347 phase I clinical trial

Concert Pharmaceuticals, Inc. announced today that it has initiated a Phase I study in healthy volunteers to evaluate the safety, tolerability and pharmacokinetics of CTP-347, a novel deuterium-containing serotonin modulator created by Concert researchers.

25 Sep 2008

New pig model of cystic fibrosis provides better understanding of human disease

For the first time, researchers have developed a genetically altered animal model for cystic fibrosis (CF) that closely matches the characteristics of the disease in humans. By studying the complex and multi-organ disease process in the pig model, researchers can now better understand how the complications of CF develop, an advancement that may lead to new avenues for research in prevention and treatment.

25 Sep 2008

Gene variant boosts risk of fatty liver disease

Researchers at UT Southwestern Medical Center have found that individuals who carry a specific form of the gene PNPLA3 have more fat in their livers and a greater risk of developing liver inflammation.

25 Sep 2008

Blacks' mortality rate after liver surgery two times higher than that of whites

Blacks have a mortality rate after liver surgery that is about twice as high as that of whites, according to a study published in the September issue of the Journal of the American College of Surgery, Reuters Health reports.

22 Sep 2008